Company
Eisbach Bio GmbH
Eisbach Bio GmbH has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| EIS-12656 | Phase 1/2 | Advanced Solid Tumor |
Latest
No recent events.
Follow Eisbach Bio GmbH on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.